发布求助

文献互助智能选刊最新文献

Therapeutic Advances in Gastroenterology

查看最新文献

2930

中科院SCI期刊分区 WOS期刊分区历年影响因子历年发表同类期刊

期刊缩写：

THER ADV GASTROENTER

影响因子：

4.2

ISSN：

print: 1756-2848
on-line: 1756-2848

研究领域：

Medicine-Gastroenterology

自引率：

2.40%

Gold OA文章占比：

88.44%

原创研究文献占比：

67.59%

SCI收录类型：

Science Citation Index Expanded (SCIE) || Scopus (CiteScore) || Directory of Open Access Journals (DOAJ)

期刊官网：

https://journals.sagepub.com/home/tag https://us.sagepub.com/en-us/nam/journal/therapeutic-advances-gastroenterology

期刊介绍英文：

Therapeutic Advances in Gastroenterology is an open access journal which delivers the highest quality peer-reviewed original research articles, reviews, and scholarly comment on pioneering efforts and innovative studies in the medical treatment of gastrointestinal and hepatic disorders. The journal has a strong clinical and pharmacological focus and is aimed at an international audience of clinicians and researchers in gastroenterology and related disciplines, providing an online forum for rapid dissemination of recent research and perspectives in this area. The editors welcome original research articles across all areas of gastroenterology and hepatology. The journal publishes original research articles and review articles primarily. Original research manuscripts may include laboratory, animal or human/clinical studies – all phases. Letters to the Editor and Case Reports will also be considered.

发文信息

中科院SCI期刊分区

大类	小类	TOP期刊	综述期刊
3区医学	4区胃肠肝病学 GASTROENTEROLOGY & HEPATOLOGY	否	否

WOS期刊分区

历年影响因子

2021年	4.4090
2022年	4.2000

历年发表

2012年	34
2013年	44
2014年	20
2015年	59
2016年	79
2017年	63
2018年	72
2019年	99
2020年	136
2021年	132
2022年	103

投稿信息

出版语言：

English

出版国家(地区)：

United Kingdom

投稿网址：

http://www.sagepub.com/journals/Journal201897#submission-guidelines

出版商：

SAGE Publications Ltd

编辑部地址：

1 OLIVERS YARD, 55 CITY ROAD, LONDON, ENGLAND, EC1Y 1SP

PubMed链接：

http://www.ncbi.nlm.nih.gov/nlmcatalog?term=1756-2848%5BISSN%5D

Therapeutic Advances in Gastroenterology - 最新文献

Clarithromycin sustained-release tablet may be an improper therapy for the eradication of Helicobacter pylori.

Pub Date : 2024-09-14 DOI: 10.1177/17562848241275332 Xingsheng Zuo,Qingli Shen,Jing Luo,Yaqin Wang,Chenglong Zhao

Enhancing self-management of patients with inflammatory bowel disease: the role of autonomy support in health goal pursuit.

Pub Date : 2024-09-10 DOI: 10.1177/17562848241275315 Barbara Horvát,Kata Orbán,Anett Dávid,Viola Sallay,Beatrix Rafael,Sanela Njers,Tamás Molnár,Márta Csabai,Georgina Csordás,Tamás Martos

High serum levels of ustekinumab are associated with better clinical outcomes during maintenance treatment for inflammatory bowel disease.

Pub Date : 2024-09-09 DOI: 10.1177/17562848241271980 Jaime González-Antuña,Teresa Valdés-Delgado,Belén Maldonado-Pérez,María Belvis-Jiménez,Luisa Castro-Laria,Vicente Merino-Bohórquez,Miguel Ángel Calleja-Hernández,Paula Castro-Martínez,Cloe Charpentier,Federico Argüelles-Arias

查看全部

免责声明：
本页显示期刊或杂志信息，仅供参考学习，不是任何期刊杂志官网，不涉及出版事务，特此申明。如需出版一切事务需要用户自己向出版商联系核实。若本页展示内容有任何问题，请联系我们，邮箱：info@booksci.cn，我们会认真核实处理。